NOTCH1 and acute lymphoblastic leukemia: In the GRAALL-2003 and -2005 trials with 212 adult T-ALL patients, RAS/PTEN mutations conferred poor prognosis and NOTCH1/FBXW7 mutations conferred favorable prognosis but only in the absence of RAS/PTEN abnormalities [40].